Abstract : SH3YL1, a novel protein containing one Src homology 3 domain at the carboxyl terminus was first detected in mouse anagen skin cDNA. This protein had a significant homology with YHRO 16c/Ysc 84, the yeast Src homology 3 domain-containing protein. The sequence identity was remarkable at the carboxyl and amino-terminal Src homology 3 domain, suggesting that the novel protein is a mouse homolog of the yeast protein and thus was termed as SH3YL1. SH3YL1 is composed of two domains, a DUF500 at N-termini and a SH3 domain at C-termini. In our study we cloned the SH3 domain in bacterial expression system in Escherichia coli using pET32a vector with TEV protease cleavage site and purified as a monomer using affinity chromatography. The N-terminal poly-Histidine tag was cleaved with TEV protease and target protein was used for backbone studies. Our study showed that SH3 domain primarily consists of β-sheet which is in consistence with previous result performed on the truncated SH3 domain of SH3YL1.
INTRODUCTION
SH3YL1 consists of a DUF500 and a SH3 (Src homology 3) domain at N-and C-termini respectively. SH3YL1 was first discovered in the mouse cDNA of mouse anagen skin 1 . The whole protein comprises of 323 amino acids and has a size of around 35.5 KDa. NOX1, an NADPH 106 Expression, Purification and NMR studies of SH3YL1 SH3 domain oxidase expressed predominantly in colon epithelium, which shows a high degree of similarity to the phagocyte NADPH oxidase helps protect the cell by producing superoxide 2 .
Within the NOX1 complex the interaction between the SH3 domain of cytosolic NOXA1 with PRR domain of NOXO1 is crucial for NOX1 acivation [3] [4] [5] [6] . The SH3 domain typically binds to the proline-rich region [7] [8] [9] . However, the interaction between the NOXA1 and NOXO1 is terminated upon the involvement of SH3 domain of SH3YL1. We hope to find out the molecular mechanism of this behavior using structural analysis and get an insight as to how it works. Furthermore, sequence comparison between the SH3YL1_SH3 domain and NOXA1_SH3 domain showed high degree of similarity, which could be the cause for SH3 domain of SH3YL1 interacting with NOXO1 and in turn displacing the SH3 domain of NOXA1 causing the inhibition of NOXA1-NOXO1 interaction.
In this report, we present the cloning, expression, purification and backbone assignment 10,11 of SH3 domain of SH3YL1. Additionally we also performed the TALOS analysis 12 for its secondary structure prediction which will be beneficial in the future studies in understanding the overall inhibition mechanism of this SH3YL1 SH3 domain in NOXA1-NOXO1 interaction.
EXPERIMENTAL
Cloning and expression of SH3 domain of SH3YL1. The full length SH3YL1 was obtained from EWHA Women's University. SH3 (Src Homology 3 domain) was cloned in the expression vector, pET32a containing a TRX and poly-Histidine tag at Nterminal. PCR (Polymerase Chain Reaction) was used to amplify the SH3 domain from full SH3YL1
with BamHI/XhoI restriction site. TEV recognition site (ENLYFQG) was included in the sense primer to later aid in the cleavage of the target SH3 domain from the recombinant fusion partner. 
Purification of SH3 domain
The cell containing fusion SH3 protein (TRX-His (6) -TEV-Target protein), were sonicated in lysis buffer (25 mM NaPi, 300 mM Nacl, 5 mM β-mercaptoethanol, pH 7. 
RESULTS AND DISCUSSION

Domain construct of SH3YL1 SH3 domain
We designed the construct of SH3 domain from 256 -323 amino acid. SH3 domain (256 -323) was cloned in the E. coli over-expression vector, pET32a, and was expressed as TRX_His (6) _TEV protease recognition sequence_target protein (Fig. 1A) . Sequence alignment for SH3 domain from SH3YL1 already studied (SH3YL1_SH3_P); SH3YL1 and NOXA1 were executed using CLUSTALW, EBI (Fig. 1B) . All three sequences showed high homology with each other suggesting they share similar structure and may be function as well. (Fig. 2 A and 2 B) . NMR spectrum recorded in 10 mM HEPES, 100 mM NaCl, 2 mM DTT, 0.01% NaN 3 , pH 6.5 at 25 o C.
Expression, Purification and NMR studies of SH3YL1 SH3 domain
Size exclusion chromatography of SH3YL1_SH3
To further purify the SH3 domain and to know the actual size of the target protein, we performed the gel filtration experiment (Fig. 2C ) using HiLoad TM 16/60 Superdex TM 75 and confirmed the target protein existed in monomeric state shown by a peak in the graph from 84 ml to 100 ml.
Structural studies of SH3YL1_SH3 domain
In order to perform the backbone assignment we first performed 1 H NMR spectroscopy which showed a stable protein sample condition (Fig. 2D ). We next performed 1 H-15 N HSQC experiments with different buffer conditions( Fig. 3A and 3B ) and found that Buffer 2 (10 mM HEPES; 100 mM NaCl; 2 mM DTT; 0.01 % NaN 3 and pH 6.5) was the optimum buffer condition for NMR studies.
The spectrum in Buffer 2 was clear with most of the peaks seen in it, so we choose this buffer condition for backbone assignments. Backbone Assignment was completed using the 1 H-15 N HSQC, HNCACB, CBCACONH and HNCA NMR spectrum. For the Backbone assignment SPARKY program was used and all the backbone residues were assigned completely (Fig. 3C) . The secondary structure was predicted from TALOS analysis along with PSI-PRED program (Fig. 4 A, B and C) . 
CONCLUSION
SH3 domain of SH3YL1 has been successfully cloned into E. coli expression vector, with TEV cleavage site. The SH3 domain was purified using Ni_NTA open column and gel filtration chromatography as a monomer. Furthermore study of its secondary structure showed that SH3 domain structure is dominated by β-strand, 5 β-strands in this case. This study will help in further understanding as to how the SH3 domain of SH3YL1 inhibits the NOXA1-NOXO1 interaction in NOX1 complex.
